SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001585364-20-000046
Filing Date
2020-04-30
Accepted
2020-04-30 08:04:04
Documents
15
Period of Report
2020-04-30
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K cy20q1earningsrelease8.htm   iXBRL 8-K 66803
2 EXHIBIT 99.1 cy20q1ex991pressrelease.htm EX-99.1 822354
  Complete submission text file 0001585364-20-000046.txt   1076765

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT prgo-20200430.xsd EX-101.SCH 4441
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT prgo-20200430_cal.xml EX-101.CAL 618
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT prgo-20200430_def.xml EX-101.DEF 1468
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT prgo-20200430_lab.xml EX-101.LAB 27020
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT prgo-20200430_pre.xml EX-101.PRE 14036
17 EXTRACTED XBRL INSTANCE DOCUMENT cy20q1earningsrelease8_htm.xml XML 4245
Mailing Address 515 EASTERN AVENUE ALLEGAN MI 49010
Business Address THE SHARP BUILDING HOGAN PLACE DUBLIN 2 L2 D02 TY74 269-673-8451
PERRIGO Co plc (Filer) CIK: 0001585364 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36353 | Film No.: 20833234
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences